Latest NewsTechnology Secures $11 Million in Series A Funding to Transform Diabetes Management, a health-tech startup that seeks to manage and reverse Type 2 and Pre-diabetes through a holistic, science-backed, and data-driven digital health experience, has announced its $11 million Series A funding round today. The funding was led by MassMutual Ventures with participation from existing investors including, Tanglin Venture Partners, and Endiya Partners. The fresh capital will be used to expand’s product offering, launch an offline presence, and accelerate research and development in the field of diabetes management, accelerating the brand’s footprint and growth.

Diabetes is the primary catalyst for various life-threatening health complications and the demand for innovative solutions in diabetes management has never been more urgent in India, an estimated 100 million individuals struggle with Type 2 diabetes, and another 130 million are on the brink of pre-diabetes. offers a complete diabetes care program by integrating a variety of devices such as continuous glucose monitors, fitness trackers and other health diagnostics and providing easy access to a diabetes specialists and health coaches. This enables users to track the real-time impact of their lifestyle on glucose levels, and receive personalised, timely guidance across the aspects of fitness, nutrition and sleep from their care team. This continuous approach to diabetes care has yielded positive health outcomes for consumers – users have seen an average 2% reduction in HbA1c levels after 3 months.

Madan Somasundaram, co-founder & CEO of said, “We are grateful for the trust and support our investors have in us. We are more committed than ever to help people with Type 2 and pre-diabetes manage and reverse their condition. This investment will enable us to further enhance our technology and expand our reach across India, ultimately helping more people take control of their diabetes and improve their health.”

Anvesh Ramineni, Managing Partner at MassMutual Ventures said, “We are thrilled to lead the Series A funding round for The team’s approach to diabetes management combines hardware, software and analytics to deliver a personalized program and drive lasting behavioral change for better health outcomes. We believe will transform the health of millions, while battling the increasing incidence of diabetes in India.”

Mukesh Bansal, Founder of said, “We are very proud of the progress has made in the last two years. This is the best team in this space with the strongest diabetes reversal metrics. We believe will revolutionise the market and help millions of Indians in reversing the disease.”

Founded in 2021, initially raised $10 million in a seed funding round and has since proven exceptional growth. In the last 18 months, the brand has witnessed eightfold growth in paid subscribers, and currently serves more than 25,000 users on its platform.

Today we live in a T-shaped world. While broad knowledge across the ecosystems is critical, deep insights and expertise of Subject Matter Experts help organizations leapfrog. At IndiaTechnologyNews, we cover much more than news, views and analysis, and we feature SMEs to help translate their knowledge to wider audiences. Reach me at

You may also like

More in Latest News